/C O R R E C T I O N -- DarioHealth Corp./
DarioHealth Corp. (NASDAQ: DRIO) has announced a new partnership with a large regional health plan, an affiliate of a top 10 national health plan, expanding its presence in the digital health market. The agreement, effective January 2025, integrates Dario's AI-driven health coaching platform into the health plan's member services.
The partnership focuses on comprehensive cardiometabolic digital health solutions, including programs for diabetes, hypertension, and weight management. This marks Dario's ninth health plan partnership, contributing to the company's annual recurring revenue (ARR) in Q1 2025, with potential for further expansion throughout the year.
The agreement positions Dario strategically in the cardiometabolic disease market, which is projected to exceed $1.2 trillion by 2033. The company's AI-driven platform continues to gain traction among payers seeking scalable, data-driven solutions that deliver measurable health improvements and cost efficiencies.
DarioHealth Corp. (NASDAQ: DRIO) ha annunciato una nuova partnership con un grande piano sanitario regionale, affiliato a uno dei primi 10 piani sanitari nazionali, espandendo la sua presenza nel mercato della salute digitale. L'accordo, che entrerà in vigore a gennaio 2025, integra la piattaforma di coaching sanitario basata sull'IA di Dario nei servizi per i membri del piano sanitario.
La partnership si concentra su soluzioni digitali complete per la salute cardiometabolica, inclusi programmi per il diabete, l'ipertensione e la gestione del peso. Questo segna la nona partnership di Dario con un piano sanitario, contribuendo ai ricavi ricorrenti annuali (ARR) dell'azienda nel primo trimestre del 2025, con potenziale per ulteriori espansioni nel corso dell'anno.
L'accordo posiziona Dario strategicamente nel mercato delle malattie cardiometaboliche, che si prevede supererà 1,2 trilioni di dollari entro il 2033. La piattaforma basata sull'IA dell'azienda continua a guadagnare terreno tra i pagatori che cercano soluzioni scalabili e basate sui dati che offrano miglioramenti misurabili nella salute e efficienze nei costi.
DarioHealth Corp. (NASDAQ: DRIO) ha anunciado una nueva asociación con un gran plan de salud regional, afiliado a uno de los 10 principales planes de salud nacionales, ampliando su presencia en el mercado de la salud digital. El acuerdo, que entrará en vigor en enero de 2025, integra la plataforma de coaching de salud impulsada por IA de Dario en los servicios para miembros del plan de salud.
La asociación se centra en soluciones digitales completas para la salud cardiometabólica, incluidos programas para la diabetes, la hipertensión y el manejo del peso. Esta es la novena asociación de Dario con un plan de salud, contribuyendo a los ingresos recurrentes anuales (ARR) de la empresa en el primer trimestre de 2025, con potencial para una mayor expansión a lo largo del año.
El acuerdo posiciona a Dario estratégicamente en el mercado de enfermedades cardiometabólicas, que se proyecta que superará 1,2 billones de dólares para 2033. La plataforma impulsada por IA de la empresa sigue ganando tracción entre los pagadores que buscan soluciones escalables y basadas en datos que ofrezcan mejoras medibles en la salud y eficiencias en costos.
다리오헬스 주식회사 (NASDAQ: DRIO)가 10대 국가 건강 계획 중 하나의 제휴사인 대규모 지역 건강 계획과 새로운 파트너십을 발표하며 디지털 건강 시장에서의 입지를 확장했습니다. 2025년 1월 발효되는 이 계약은 다리오의 AI 기반 건강 코칭 플랫폼을 건강 계획의 회원 서비스에 통합합니다.
이번 파트너십은 포괄적인 심혈관 대사 디지털 건강 솔루션에 중점을 두고 있으며, 당뇨병, 고혈압 및 체중 관리 프로그램을 포함합니다. 이는 다리오의 아홉 번째 건강 계획 파트너십으로, 2025년 1분기 회사의 연간 반복 수익(ARR)에 기여하며, 올해 중 추가 확장의 가능성이 있습니다.
이 계약은 다리오를 심혈관 대사 질환 시장에서 전략적으로 자리매김하게 하며, 이 시장은 2033년까지 1.2조 달러를 초과할 것으로 예상됩니다. 회사의 AI 기반 플랫폼은 측정 가능한 건강 개선 및 비용 효율성을 제공하는 확장 가능한 데이터 기반 솔루션을 찾는 지불자들 사이에서 계속해서 인기를 얻고 있습니다.
DarioHealth Corp. (NASDAQ: DRIO) a annoncé un nouveau partenariat avec un grand plan de santé régional, affilié à l'un des 10 principaux plans de santé nationaux, élargissant ainsi sa présence sur le marché de la santé numérique. L'accord, qui prendra effet en janvier 2025, intègre la plateforme de coaching de santé pilotée par IA de Dario dans les services aux membres du plan de santé.
Le partenariat se concentre sur des solutions numériques complètes pour la santé cardiométabolique, y compris des programmes pour le diabète, l'hypertension et la gestion du poids. Cela marque le neuvième partenariat de Dario avec un plan de santé, contribuant aux revenus récurrents annuels (ARR) de l'entreprise au premier trimestre 2025, avec un potentiel d'expansion supplémentaire tout au long de l'année.
L'accord positionne Dario de manière stratégique sur le marché des maladies cardiométaboliques, qui devrait dépasser 1,2 trillion de dollars d'ici 2033. La plateforme pilotée par IA de l'entreprise continue de gagner du terrain parmi les payeurs recherchant des solutions évolutives et basées sur les données qui offrent des améliorations mesurables en matière de santé et des gains d'efficacité en matière de coûts.
DarioHealth Corp. (NASDAQ: DRIO) hat eine neue Partnerschaft mit einem großen regionalen Gesundheitsplan angekündigt, der zu einem der 10 größten nationalen Gesundheitspläne gehört, und damit seine Präsenz im digitalen Gesundheitsmarkt erweitert. Die Vereinbarung, die im Januar 2025 in Kraft tritt, integriert Darios KI-gesteuerte Gesundheits-Coaching-Plattform in die Mitgliederdienste des Gesundheitsplans.
Die Partnerschaft konzentriert sich auf umfassende digitale Gesundheitslösungen für die kardiometabolische Gesundheit, einschließlich Programme für Diabetes, Bluthochdruck und Gewichtsmanagement. Dies markiert Darios neunte Partnerschaft mit einem Gesundheitsplan und trägt zu den wiederkehrenden Jahresumsätzen (ARR) des Unternehmens im ersten Quartal 2025 bei, mit Potenzial für weitere Expansion im Laufe des Jahres.
Die Vereinbarung positioniert Dario strategisch im Markt für kardiometabolische Erkrankungen, dessen Wert bis 2033 voraussichtlich 1,2 Billionen Dollar übersteigen wird. Die KI-gesteuerte Plattform des Unternehmens gewinnt weiterhin an Bedeutung bei Leistungsträgern, die skalierbare, datengestützte Lösungen suchen, die messbare Gesundheitsverbesserungen und Kosteneffizienzen bieten.
- None.
- None.
In the news release, DarioHealth Announces New Blue Cross Blue Shield Agreement, Expanding Health Plan Client Base, issued 06-Feb-2025 by DarioHealth Corp. over PR Newswire, we are advised by the company to make multiple changes to the press release. The complete, corrected release follows:
DarioHealth Announces New Agreement with a Large Regional Health Plan
DarioHealth expands its payer network with a new regional health plan, an affiliate of one of the top 10 national health plans, bolstering recurring revenue growth and reinforcing its position in one of healthcare's fastest-growing sectors; Dario's AI-driven digital health platform continues to drive adoption among payers seeking scalable, data-driven solutions
This agreement will integrate the Dario platform's comprehensive cardiometabolic digital health solutions, including programs for diabetes, hypertension, and weight management, into the health plan's suite of member services offered to employers. The agreement is already contributing to the Company's annual recurring revenue (ARR) in Q1 2025, and as with many of the contracts launched in January of 2025, the relationship with this health plan is expected to expand further throughout the year to cover more of the plan's population.
This new plan is an affiliate of a trusted leader in healthcare across the
"We believe that this expansion highlights the increasing demand among payers for scalable, AI-driven digital health solutions that deliver measurable health improvements and cost efficiencies," said Steven Nelson, Chief Commercial Officer at Dario. " We believe that securing this health plan further validates our market leadership in cardiometabolic care and reinforces our ability to scale recurring revenue growth. With nine health plans now leveraging our technology, we are rapidly expanding our presence in the multi-billion-dollar payer market and strengthening our trajectory toward profitability and long-term growth."
About DarioHealth Corp.
DarioHealth Corp. (NASDAQ: DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Dario's platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health.
Dario's user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results and making the right thing to do the easy thing to do.
Dario provides its highly user-rated solutions globally to health plans and other payers, self-insured employers, providers of care and consumers. To learn more about Dario and its digital health solutions, or for more information, visit http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the integration of the Dario platform's digital health solutions into the regional health plan, the expectancy that the collaborations with the Company's current health plans will expand further throughout the year to cover more populations, the Company's expanding role in delivering digital cardiometabolic care solutions nationwide, projections with respect to the cardiometabolic disease market, the increasing demand among payers for scalable, AI-driven digital health solutions, and the Company's ability to scale recurring revenue growth, profitability and long-term growth. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the
1https://straitsresearch.com/report/cardiometabolic-disease-market
DarioHealth Corporate Contact
Mary Mooney
VP Marketing
mary@dariohealth.com
+1-312-593-4280
DarioHealth Investor Relations Contact
Kat Parrella
Investor Relations Manager
kat@dariohealth.com
+315-378-6922
Logo - https://mma.prnewswire.com/media/1920436/DarioHealth_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/dariohealth-announces-new-blue-cross-blue-shield-agreement-expanding-health-plan-client-base-302370044.html
SOURCE DarioHealth Corp.
FAQ
What is the scope of DarioHealth's new health plan agreement announced in March 2025?
How many health plans does DRIO now serve after this new agreement?
What is the projected market size for cardiometabolic disease by 2033?
When did DRIO implement this new health plan partnership?
What specific health solutions does DRIO offer through this new partnership?
